Skip to content

Saturday, December 13, 2025

Latest:

From symptoms to solutions: How new guidelines are changing UTI care in spinal cord injury patients
Research suggests that Alzheimer’s disease may develop through distinct biological pathways
Sweat vs. sweets: The workout math behind holiday treats
Researchers make strides toward preventing parenteral nutrition-associated liver disease
A new approach to treating overactive bladder

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

5D4

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: Human intestinal organoid

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951